Discover 1,665 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,665
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase1, Phase2, Recruiting
Active & Responsive
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Tampa FL, Newnan GA, Grand Rapids MI, Denver CO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07409246
Phase1, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Fairfax VA, Chicago IL, San Antonio TX, Denver CO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07278336
Phase1, Recruiting
Featured
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
for
Primary Open Angle Glaucoma
Location: Philadelphia PA, Bala-Cynwyd PA, Charlottesville VA,
Sponsor: AbbVie
Sex: All
Age: 45+
Code: NCT06822738
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Halifax, Boston MA, Hartford CT, New York NY, Montreal,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT06332534
Phase3, Recruiting
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Providence RI, Worcester MA, New Haven CT, New York NY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase3, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for
Crohn's Disease
Location: New Bedford MA, New Haven CT, Quebec, Danbury CT,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06548542
Phase2, Recruiting
Featured
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: New York NY, Fairfax VA, Chapel Hill NC, Roanoke VA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07095452
Phase2, Phase3, Recruiting
FeaturedActive & Responsive
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Sherbrooke, Great Neck NY, West Long Branch NJ,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06972446
Phase2, Recruiting
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Philadelphia PA, Virginia Beach VA, Burke VA, Miami FL,
Sponsor: Expedition Therapeutics, Inc
Sex: All
Age: 40 - 70+
Code: NCT07684820
Phase2, Recruiting
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07630974
Phase1, Phase2, Recruiting
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
for
HER2 Expressing Solid Tumors
Location: New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT07192432
Phase1, Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
for
Myasthenia Gravis
Location: New Bern NC, Clearwater FL, Farmington Hills MI,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07673744
Phase2, Recruiting
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
for
Pulmonary Hypertension, Interstitial Lung Disease
Location: Charleston SC, Orlando FL, Tampa FL, Indianapolis IN,
Sponsor: Liquidia Technologies, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06129240
Recruiting
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
for
Proteinuric Kidney Diseases
Location: Mineola NY, Clifton Park NY, Boca Raton FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 12+
Code: NCT07355296
Phase2, Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: St. John's, Portsmouth NH, Brighton MA, Milford MA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Metastatic Gastric Adenocarcinoma,
Location: Westbrook ME, Florham Park NJ, Flemington NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07043400
Phase3, Recruiting
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)